Evercore Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Evercore Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-80	Closed	-$10K	–	1001
2015 Q2	$10K	Hold	80	–	–	﹤0.01%	906
2015 Q1	$9K	Buy	+80	New	+$9.04K	﹤0.01%	876
2014 Q4	–	Sell	-80	Closed	-$7K	–	900
2014 Q3	$7K	Hold	80	–	–	﹤0.01%	844
2014 Q2	$7K	Hold	80	–	–	﹤0.01%	871
2014 Q1	$6K	Hold	80	–	–	﹤0.01%	847
2013 Q4	$6K	Buy	+80	New	+$5.25K	﹤0.01%	789

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TFA

Transamerica Financial Advisors St. Petersburg, Florida $1.17B AUM 23.36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Evercore Wealth Management's FBT Position: Q3 2015 in Review

Evercore Wealth Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2015, closing a stake of 80 shares — an estimated $10K sold.

Evercore Wealth Management first reported a position in FBT in Q4 2013 and held it in 6 quarters. The position peaked at $10K in Q2 2015. 126 funds tracked by Wall St. Rank hold FBT as of Q3 2015.

Evercore Wealth Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2015 after selling out during the quarter.
Evercore Wealth Management sold 80 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2015, an estimated $10K.
Evercore Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2013 and held it in 6 quarters.
Evercore Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $10K in Q2 2015.
126 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2015.

Based on Evercore Wealth Management's 13F filing for Q3 2015, filed 16 Nov 2015.